|
|
|
|
|
|
News and Articles on ICON PLC (ICLR)
ICON Central Laboratories in Singapore Moves to New Facility to Meet Growing Demand Jun 26, 2009
ICON plc (NASDAQ:ICLR: ISIN: IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has moved its Singapore central laboratory to a new, larger facility located at Loyang Way, Eastern Singapore ... ICON Central Laboratories, a division of ICON plc, provides full service, global central laboratory services from core facilities in New York, Dublin, Singapore and India, as well as through... (PR Newswire)
New Safety Regulations Drive Greater Need for Resources and Expertise at Every Stage of Clinical Development Jun 18, 2009
The report was commissioned by ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, and developed by IMS Health, the world's leading provider of market intelligence to the pharmaceutical and healthcare industries ... ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. (PR Newswire)
ICON Acquires Assets of Qualia Clinical Services, Inc. Apr 28, 2009
Press Release Source: ICON plc ... DUBLIN, Ireland, April 28, 2009 (GLOBE NEWSWIRE) -- ICON plc (NasdaqGS: - ) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has acquired a 33,000-square-foot Phase I facility with a capacity of up to 100 beds in Omaha, Nebraska, having acquired the assets of the former Qualia Clinical Services, Inc. ... ICON plc is a global provider of... (Primezone Releases)
ICON Reports 9% Increase in Revenue, 25% Increase in EPS and Acquisition of a U.S. Phase I Facility Apr 28, 2009
Press Release Source: ICON plc ... ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries ... ICON plc Consolidated Income Statements (Unaudited) Three Months ended March 31, 2009 and March 31, 2008 (Dollars, in thousands, except share and per share data) Three Months Ended March 31, March 31, 2009 2008 Gross Revenue 318,538 283,853 Reimbursable expenses 98,707 82,509 ---------- ---------- Net Revenue 219,831 201,344... (Primezone Releases)
[ Terms Of Use | Privacy | About ]
©1998-2006 SurfWax, Inc.
All rights reserved. Patents pending.
|
|
|
Copyright SurfWax, Inc. 2006
|
|
